What really surprised me is that Peloton Pharm was "supposed to be a new IPO" and look at the people involved....formed big guys from KITE (GILD bought them out) and another player from ARRY (another pathway company)....Man, they moved fast....pathways are moving fast.
That's what our immune system is, "a swarm of hunter-killer cells personalized to the individual". Multikine is as good a way as any to overcome a tumor's suppression of this "swarm" and stimulate it to attack the cancer. This is a very exciting trial of the idea that the immune system can be induced to reduce or eliminate tumors and likely establish an immune memory to guard against recurrence. The fact that it has gone on this long without reaching the endpoint is very encouraging and every day is more exciting than the last, especially for the trial volunteers who are benefitting. I doubled my position at 5.41 pps and will again when funds become available.
News 
Market Data 
Discover 
AI
